Literature DB >> 15659593

Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum.

Jie Liu1, Baojian Yu, Luis Orozco-Cabal, Dimitri E Grigoriadis, Jean Rivier, Wylie W Vale, Patricia Shinnick-Gallagher, Joel P Gallagher.   

Abstract

Corticotropin-releasing factor (CRF) and urocortin (Ucn I) are endogenous members among a family of CRF-related peptides that activate two different and synaptically localized G-protein-coupled receptors, CRF1 and CRF2. These peptides and their receptors have been implicated in stress responses and stress with cocaine abuse. In this study, we observed significant alterations in excitatory transmission and CRF-related peptide regulation of excitatory transmission in the lateral septum mediolateral nucleus (LSMLN) after chronic cocaine administration. In brain slice recordings from the LSMLN of control (saline-treated) rats, glutamatergic synaptic transmission was facilitated by activation of CRF1 receptors with CRF but was depressed after activation of CRF2 receptors with Ucn I. After acute withdrawal from a chronic cocaine administration regimen, CRF1 activation remained facilitatory, but CRF2 activation facilitated rather than depressed LSMLN EPSCs. These alterations in CRF2 effects occurred through both presynaptic and postsynaptic mechanisms. In saline-treated rats, CRF1 and CRF2 coupled predominantly to protein kinase A signaling pathways, whereas after cocaine withdrawal, protein kinase C activity was more prominent and likely contributed to the CRF2-mediated presynaptic facilitation. Neither CRF nor Ucn I altered monosynaptic GABA(A)-mediated IPSCs before or after chronic cocaine administration, suggesting that loss of GABAA-mediated inhibition could not account for the facilitation. This switch in polarity of Ucn I-mediated neuromodulation, from a negative to positive regulation of excitatory glutamatergic transmission after chronic cocaine administration, could generate an imbalance in the brain reward circuitry associated with the LSMLN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659593      PMCID: PMC6725320          DOI: 10.1523/JNEUROSCI.4196-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

Review 1.  7TM receptors: the splicing on the cake.

Authors:  G J Kilpatrick; F M Dautzenberg; G R Martin; R M Eglen
Journal:  Trends Pharmacol Sci       Date:  1999-07       Impact factor: 14.819

Review 2.  Neuropeptides--an overview.

Authors:  T Hökfelt; C Broberger; Z Q Xu; V Sergeyev; R Ubink; M Diez
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

3.  Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment.

Authors:  Steven C Stout; Michael J Owens; Charles B Nemeroff
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

4.  Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region.

Authors:  R J Valentino; C Rudoy; A Saunders; X B Liu; E J Van Bockstaele
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 5.  The role of corticotropin-releasing factor in drug addiction.

Authors:  Z Sarnyai; Y Shaham; S C Heinrichs
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

6.  Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala.

Authors:  V Neugebauer; F Zinebi; R Russell; J P Gallagher; P Shinnick-Gallagher
Journal:  J Neurophysiol       Date:  2000-08       Impact factor: 2.714

7.  Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention.

Authors:  M Sauvage; T Steckler
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

8.  Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins.

Authors:  D K Grammatopoulos; H S Randeva; M A Levine; K A Kanellopoulou; E W Hillhouse
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

9.  Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro.

Authors:  C W Vaughan; M Connor; E A Jennings; S Marinelli; R G Allen; M J Christie
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

10.  Expression of Fos-related antigens in the nucleus accumbens and associated regions following exposure to a cocaine-paired environment.

Authors:  T R Franklin; J P Druhan
Journal:  Eur J Neurosci       Date:  2000-06       Impact factor: 3.386

View more
  32 in total

1.  Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine.

Authors:  William J Giardino; Gregory P Mark; Mary P Stenzel-Poore; Andrey E Ryabinin
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2.

Authors:  Jordan M Blacktop; Chad Seubert; David A Baker; Nathan Ferda; Geng Lee; Evan N Graf; John R Mantsch
Journal:  J Neurosci       Date:  2011-08-03       Impact factor: 6.167

3.  Adrenal activity during repeated long-access cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats.

Authors:  Evan N Graf; Michael A Hoks; Jean Baumgardner; Jose Sierra; Oliver Vranjkovic; Colin Bohr; David A Baker; John R Mantsch
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

4.  Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects.

Authors:  Melissa A Herman; Florence P Varodayan; Christopher S Oleata; George Luu; Dean Kirson; Markus Heilig; Roberto Ciccocioppo; Marisa Roberto
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

5.  CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats.

Authors:  Florence P Varodayan; Diego Correia; Dean Kirson; Sophia Khom; Christopher S Oleata; George Luu; Paul Schweitzer; Marisa Roberto
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

6.  CRF-R2 and the heterosynaptic regulation of VTA glutamate during reinstatement of cocaine seeking.

Authors:  Courtney L Williams; William C Buchta; Arthur C Riegel
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

Review 7.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

Review 8.  Synaptic physiology of central CRH system.

Authors:  Joel P Gallagher; Luis F Orozco-Cabal; Jie Liu; Patricia Shinnick-Gallagher
Journal:  Eur J Pharmacol       Date:  2008-02-01       Impact factor: 4.432

9.  Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption.

Authors:  A E Ryabinin; N Yoneyama; M A Tanchuck; G P Mark; D A Finn
Journal:  Neuroscience       Date:  2007-11-19       Impact factor: 3.590

Review 10.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Authors:  M R Bruchas; B B Land; C Chavkin
Journal:  Brain Res       Date:  2009-08-28       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.